Back to trial detailsIntake questionnaire
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Applying to University of Kentucky-Lexington · Lexington, Kentucky
Answer a few short questions to share with the research team.
0 of 4 answered